Skip to main content
Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
209.14
+3.42 (1.66%)
At close: Aug 13, 2025, 4:00 PM
208.71
-0.43 (-0.21%)
After-hours: Aug 13, 2025, 6:44 PM EDT

Danaher Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
9.76B 9.71B 9.79B 9.87B 9.76B 9.73B 9.58B 9.83B
Diagnostics Growth
0.01% -0.20% 2.19% 0.41% -4.82% -8.06% -11.72% -8.72%
Life Sciences
7.27B 7.26B 7.33B 7.23B 7.15B 7.18B 7.14B 7.16B
Life Sciences Growth
1.68% 1.21% 2.63% 0.98% -22.50% -37.03% -47.38% -54.33%
Biotechnology
6.98B 6.85B 6.76B 6.65B 6.66B 6.83B 7.17B 7.64B - - - - - - - - - - -
Biotechnology Growth
4.86% 0.22% -5.76% -12.93% - - - - - - - - - - - - - - -
Environmental and Applied Solutions
- - - - - - - 4.95B 4.91B 4.88B 4.83B 4.81B 4.75B 4.68B 4.65B
Environmental and Applied Solutions Growth
- - - - - - - 2.76% 3.20% 4.38% 3.81% 4.61% 5.04% 7.00% 8.04%

Operating Income by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
2.51B 2.51B 2.63B 2.77B 2.69B 2.56B 2.41B 2.63B
Diagnostics Growth
-6.69% -1.80% 9.10% 5.25% -5.61% -20.70% -29.98% -21.29%
Biotechnology
1.87B 1.74B 1.63B 1.53B 1.56B 1.64B 1.91B 2.19B - - - - - - - - - - -
Biotechnology Growth
19.87% 6.29% -14.88% -29.87% - - - - - - - - - - - - - - -
Environmental
- - - - - - - 1.19B 1.19B 1.20B 1.14B 1.06B 1.03B 1.01B 1.05B
Environmental Growth
- - - - - - - 12.34% 15.60% 19.20% 7.69% -2.84% -4.62% -1.86% 7.66%
Life Sciences
373.00M 845.00M 879.00M 738.00M 1.02B 1.12B 1.21B 1.37B
Life Sciences Growth
-63.29% -24.76% -27.30% -45.97% -51.57% -61.70% -67.58% -69.19%
Other
-337.00M -334.00M -326.00M -323.00M -358.00M -392.00M -413.00M -417.00M

Recurring Revenue
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Recurring Revenue
19.80B 19.52B 19.50B 17.04B 17.44B 18.09B 18.68B 19.17B
Recurring Revenue Growth
13.52% 7.90% 4.37% -11.11% -11.95% -11.16% -10.51% -18.76%

Revenue by Geography
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
North America
10.25B 10.25B 10.30B 10.11B 10.71B 11.20B 11.59B 12.68B - -
North America Growth
-4.30% -8.55% -11.20% -20.23% -18.75% -17.84% -17.00% -6.91% - -
High Growth Markets
6.87B 6.87B 6.87B 6.88B 7.23B 7.73B 8.28B 8.74B - -
High Growth Markets Growth
-5.03% -11.17% -17.03% -21.28% -19.12% -14.85% -9.26% -5.49% - -
Western Europe
5.66B 5.48B 5.46B 5.31B 5.58B 5.96B 6.35B 6.73B - -
Western Europe Growth
1.53% -8.17% -14.04% -21.16% -18.06% -12.16% -8.13% -2.73% - -
Other Developed Markets
1.23B 1.23B 1.25B 1.27B 1.30B 1.33B 1.38B 1.41B - -
Other Developed Markets Growth
-5.03% -7.68% -9.21% -10.53% -8.99% -7.76% -5.92% -3.15% - -

Operating Expense Breakdown
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Selling, General, and Administrative
8.30B 7.81B 7.76B 7.77B 7.86B 8.18B 8.52B 8.68B
Selling, General, and Administrative Growth
5.66% -4.53% -8.94% -10.43% -9.49% -4.55% 0.06% 0.65%
Research and Development
1.61B 1.60B 1.58B 1.55B 1.58B 1.61B 1.67B 1.72B
Research and Development Growth
1.52% -0.93% -5.21% -9.78% -7.97% -7.10% -4.24% -3.92%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.